Willner & Heller LLC Invests $642,000 in Axon Enterprise, Inc $AXON

Willner & Heller LLC bought a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,131 shares of the biotechnology company’s stock, valued at approximately $642,000.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in Axon Enterprise during the second quarter worth approximately $637,806,000. Vanguard Group Inc. lifted its stake in shares of Axon Enterprise by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock valued at $6,684,217,000 after purchasing an additional 376,904 shares during the last quarter. Jennison Associates LLC boosted its holdings in shares of Axon Enterprise by 53.8% in the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after purchasing an additional 330,213 shares during the period. 1832 Asset Management L.P. boosted its holdings in shares of Axon Enterprise by 129.2% in the 2nd quarter. 1832 Asset Management L.P. now owns 536,420 shares of the biotechnology company’s stock worth $444,124,000 after purchasing an additional 302,420 shares during the period. Finally, Winslow Capital Management LLC increased its position in shares of Axon Enterprise by 43.2% during the 2nd quarter. Winslow Capital Management LLC now owns 375,580 shares of the biotechnology company’s stock valued at $310,958,000 after purchasing an additional 113,326 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 2,000 shares of the business’s stock in a transaction dated Friday, February 27th. The shares were sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the sale, the insider directly owned 55,588 shares of the company’s stock, valued at $29,740,135.88. The trade was a 3.47% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Jennifer H. Mak sold 1,500 shares of the company’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares in the company, valued at $7,019,028. This represents a 10.92% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 23,855 shares of company stock valued at $13,299,928. Company insiders own 4.40% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on AXON shares. Robert W. Baird set a $800.00 price target on Axon Enterprise in a report on Wednesday, February 25th. Northcoast Research raised shares of Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price objective for the company in a research note on Tuesday, January 6th. UBS Group cut their price objective on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 25th. Morgan Stanley lowered their target price on shares of Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Finally, Royal Bank Of Canada dropped their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $762.93.

Axon Enterprise Price Performance

Shares of AXON stock opened at $460.15 on Thursday. The stock has a 50 day moving average price of $509.91 and a 200 day moving average price of $595.01. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The firm has a market capitalization of $37.00 billion, a P/E ratio of 302.73, a P/E/G ratio of 9.75 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.60 by $0.55. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. During the same quarter in the prior year, the company posted $2.08 EPS. Axon Enterprise’s quarterly revenue was up 38.5% on a year-over-year basis. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.